Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA:603392)

Market Cap	36.54B -57.4%
Revenue (ttm)	1.94B +2.5%
Net Income	-388.47M
EPS	-0.30
Shares Out	1.26B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,379,922
Open	28.68
Previous Close	28.90
Day's Range	28.20 - 28.92
52-Week Range	28.00 - 64.80
Beta	0.68
Analysts	Sell
Price Target	40.30 (+41.55%)
Earnings Date	Aug 21, 2026

About SHA:603392

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. research, develops, produces, and sells biological diagnostic tests and vaccines in China and internationally. The company offers in vitro diagnostics and automated laboratory instruments, including Wan600, Wan BC2800, WanTLA immunoassay and biochemistry analyzers; chemiluminescence and biochemistry tests, including novel diagnostic tests for detection of Hepatitis virus infections; P-85 Ab for nasopharyngeal cancer screening; and TB-IGRA for large population screening. It also provides di...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1991
• Employees: 4,116
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603392

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 17, 2026

Data Sources Report a data error